Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial

2018/03/18 by Jean-Philippe Collet, Jean‐Philippe Collet, Sergio Berti +13 · 20 citations
Medicine · #Cardiac Valve Diseases and Treatments #Atrial Fibrillation Management and Outcomes #Antiplatelet Therapy and Cardiovascular Diseases

paper · doi:10.1016/j.ahj.2018.03.008

Cited by

• Antithrombotic Therapy in Transcatheter Aortic Valve Replacement. [europepmc]
• Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation. [europepmc]
• Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves? [europepmc]
• A Finite Element Analysis Study from 3D CT to Predict Transcatheter Heart Valve Thrombosis. [europepmc]
• Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status. [europepmc]
• Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study. [europepmc]
• Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacement. [europepmc]
• Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement: the complexity of the elderly. [europepmc]
• 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. [europepmc]
• Percutaneous versus Surgical Intervention for Severe Aortic Valve Stenosis: A Systematic Review. [europepmc]
• Anticoagulation for atrial fibrillation in heart failure patients: balancing between Scylla and Charybdis. [europepmc]
• Risk of Bleeding after Transcatheter Aortic Valve Replacement: impact of Preoperative Antithrombotic Regimens. [europepmc]
• Real-World Anticoagulatory Treatment After Transcatheter Aortic Valve Replacement: A Retrospective, Observational Study on 4,800 Patients. [europepmc]
• Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. [europepmc]
• Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study. [europepmc]
• Periprocedural Strategies for Stroke Prevention in Patients Undergoing Transcatheter Aortic Valve Implantation. [europepmc]
• Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valve Replacement or Repair. [europepmc]
• Leaflet thrombosis in transcatheter aortic valve intervention: mechanisms, prevention, and treatment options. [europepmc]
• Dual Antiplatelet Regimens for Transcatheter Aortic Valve Replacement and Corresponding Cardiac CT Evaluation of the Leaflets: Single-center Experience. [europepmc]
• Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis. [europepmc]